Clinical Wound Healing Using Signal Inhibitors

Part of the Springer Series on Biofilms book series (BIOFILMS, volume 2)


The cases presented in this chapter demonstrate the amazing improvement in wound-healing trajectory that is best explained by the suppression of biofilms. The individual patient with a chronic wound is not much better served today than a decade ago despite all of the advances achieved. The rate of major limb amputation and mortality is not decreasing, and the quality of life of these patients is not improving. Chronic wounds have a much higher prevalence rate of biofilms than acute ones, suggesting that presence of a biofilm is an important factor in the lack of healing of chronic wounds. As shown in this chapter, the implementation of the quorum-sensing inhibitor RNAIII-inhibiting peptide in managing complex wounds, along with other anti-biofilm strategies like lactoferrin, has dramatically changed the positive outcomes for many of the most desperate wounds.


Extracellular Polymeric Substance Chronic Wound Planktonic Bacterium Extracellular Polymeric Substance Production Individual Bacterium 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Appelmelk BJ, An YQ, Geerts M, Thijs BG, de Boer HA, MacLaren DM, de Graaff J, Nuijens JH (1994) Lactoferrin is a lipid A-binding protein. Infect Immun 62:2628–2632PubMedGoogle Scholar
  2. 2.
    Arnold RR, Cole MF, McGhee JR (1977) A bactericidal effect for human lactoferrin. Science 197:263–265PubMedCrossRefGoogle Scholar
  3. 3.
    Balaban N, Stoodley P, Fux CA, Wilson S, Costerton JW, Dell'Acqua G (2005) Prevention of staphylococcal biofilm-associated infections by the quorum sensing inhibitor RIP. Clin Orthop Relat Res 437:48–54PubMedCrossRefGoogle Scholar
  4. 4.
    Brandenburg K, Jurgens G, Muller M, Fukuoka S, Koch MH (2001) Biophysical characterization of lipopolysaccharide and lipid A inactivation by lactoferrin. Biol Chem 382:1215–1225PubMedCrossRefGoogle Scholar
  5. 5.
    Bullen JJ (1975) Iron-binding proteins in milk and resistance to Escherichia coli infection in infants. Postgrad Med J 51(suppl 3):67–70PubMedGoogle Scholar
  6. 6.
    Buzato MA, Tribulatto EC, Costa SM, Zorn WG, van Bellen B (2002) Major amputations of the lower leg. The patients two years later. Acta Chir Belg 102:248–252PubMedGoogle Scholar
  7. 7.
    Costerton JW (2005) Biofilm theory can guide the treatment of device-related orthopaedic infections. Clin Orthop Relat Res 437:7–11PubMedCrossRefGoogle Scholar
  8. 8.
    Costerton JW, Stewart PS (2001) Battling biofilms. Sci Am 285:74–81PubMedCrossRefGoogle Scholar
  9. 9.
    Costerton JW, Stewart PS, Greenberg EP (1999) Bacterial biofilms: a common cause of persistent infections. Science 284:1318–1322PubMedCrossRefGoogle Scholar
  10. 10.
    Diegelmann RF (2003) Excessive neutrophils characterize chronic pressure ulcers. Wound Repair Regen 11:490–495PubMedCrossRefGoogle Scholar
  11. 11.
    Domenico P, Gurzenda E, Giacometti A, Cirioni O, Ghiselli R, Orlando F, Korem M, Saba V, Scalise G, Balaban N (2004) BisEDT and RIP act in synergy to prevent graft infections by resistant staphylococci. Peptides 25:2047–2053PubMedCrossRefGoogle Scholar
  12. 12.
    Ellison RT III, Giehl TJ, LaForce FM (1988) Damage of the outer membrane of enteric gram-negative bacteria by lactoferrin and transferrin. Infect Immun 56:2774–2781PubMedGoogle Scholar
  13. 13.
    Falanga V (2001) Introduction, overview. In: Falanga V (ed) Cutaneous wound healing. Martin Dunitz, London, p 2Google Scholar
  14. 14.
    Fux CA, Costerton JW, Stewart PS, Stoodley P (2005) Survival strategies of infectious biofilms. Trends Microbiol 13:34–40PubMedCrossRefGoogle Scholar
  15. 15.
    Katsuyama M, Kobayashi Y, Ichikawa H, Mizuno A, Miyachi Y, Matsunaga K, Kawashima M (2005) A novel method to control the balance of skin microflora. Part 2. A study to assess the effect of a cream containing farnesol and xylitol on atopic dry skin. J Dermatol Sci 38:207–213PubMedCrossRefGoogle Scholar
  16. 16.
    Ochoa TJ, Noguera-Obenza M, Ebel F, Guzman CA, Gomez HF, Cleary TG (2003) Lactoferrin impairs type III secretory system function in enteropathogenic Escherichia coli. Infect Immun 71:5149–5155PubMedCrossRefGoogle Scholar
  17. 17.
    Peters EJ, Childs MR, Wunderlich RP, Harkless LB, Armstrong DG, Lavery LA (2001) Functional status of persons with diabetes-related lower-extremity amputations. Diabetes Care 24:1799–1804PubMedCrossRefGoogle Scholar
  18. 18.
    Sauer K, Camper AK, Ehrlich GD, Costerton JW, Davies DG (2002) Pseudomonas aeruginosa displays multiple phenotypes during development as a biofilm. J Bacteriol 184:1140–1154PubMedCrossRefGoogle Scholar
  19. 19.
    Singh PK, Parsek MR, Greenberg EP, Welsh MJ (2002) A component of innate immunity prevents bacterial biofilm development. Nature 417:552–555PubMedCrossRefGoogle Scholar
  20. 20.
    Smith A (2004) Etiology of the problem wound. In: Sheffield PJ, Fife CE, Smith A (eds) Wound care practice. Best, Flagstaff, pp 3–48Google Scholar
  21. 21.
    Stoodley P, Sauer K, Davies DG, Costerton JW (2002) Biofilms as complex differentiated communities. Annu Rev Microbiol 56:187–209PubMedCrossRefGoogle Scholar
  22. 22.
    Tapiainen T, Sormunen R, Kaijalainen T, Kontiokari T, Ikaheimo I, Uhari M (2004) Ultrastructure of Streptococcus pneumoniae after exposure to xylitol. J Antimicrob Chemother 54:225–228PubMedCrossRefGoogle Scholar
  23. 23.
    Veloira WG, Domenico P, LiPuma JJ, Davis JM, Gurzenda E, Kazzaz JA (2003) In vitro activity and synergy of bismuth thiols and tobramycin against Burkholderia cepacia complex. J Antimicrob Chemother 52:915–919PubMedCrossRefGoogle Scholar
  24. 24.
    Ward PP, Uribe-Luna S, Conneely OM (2002) Lactoferrin and host defense. Biochem Cell Biol 80:95–102PubMedCrossRefGoogle Scholar
  25. 25.
    Weinberg ED (1993) The development of awareness of iron-withholding defense. Perspect Biol Med 36:215–221PubMedGoogle Scholar
  26. 26.
    Weinberg ED (2004) Suppression of bacterial biofilm formation by iron limitation. Med Hypotheses 63:863–865PubMedCrossRefGoogle Scholar
  27. 27.
    Yager DR, Nwomeh BC (1999) The proteolytic environment of chronic wounds. Wound Repair Regen 7:433–441PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2007

Authors and Affiliations

  1. 1.Southwest Regional Wound Care CenterLubbockUSA

Personalised recommendations